Circulating regulatory T cells (CD4 +CD25 +FOXP3 +) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/ neu (AE37) peptide

Autor: Gates, Jeremy D., Clifton, Guy T., Benavides, Linda C., Sears, Alan K., Carmichael, Mark G., Hueman, Matthew T., Holmes, Jarrod P., Jama, Yusuf H., Mursal, Mohamed, Zacharia, Athina, Ciano, Kathy, Khoo, Steven, Stojadinovic, Alexander, Ponniah, Sathibalan, Peoples, George E.
Zdroj: In Vaccine 2010 28(47):7476-7482
Databáze: ScienceDirect
Externí odkaz: